237 related articles for article (PubMed ID: 31058874)
21. Emerging Cytotoxic Alkaloids in the Battle against Cancer: Overview of Molecular Mechanisms.
Habli Z; Toumieh G; Fatfat M; Rahal ON; Gali-Muhtasib H
Molecules; 2017 Feb; 22(2):. PubMed ID: 28208712
[TBL] [Abstract][Full Text] [Related]
22. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
[TBL] [Abstract][Full Text] [Related]
23. Quercetin induces mitochondrial-derived apoptosis via reactive oxygen species-mediated ERK activation in HL-60 leukemia cells and xenograft.
Lee WJ; Hsiao M; Chang JL; Yang SF; Tseng TH; Cheng CW; Chow JM; Lin KH; Lin YW; Liu CC; Lee LM; Chien MH
Arch Toxicol; 2015 Jul; 89(7):1103-17. PubMed ID: 25138434
[TBL] [Abstract][Full Text] [Related]
24. Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia.
Khoury HJ; Collins RH; Blum W; Stiff PS; Elias L; Lebkowski JS; Reddy A; Nishimoto KP; Sen D; Wirth ED; Case CC; DiPersio JF
Cancer; 2017 Aug; 123(16):3061-3072. PubMed ID: 28411378
[TBL] [Abstract][Full Text] [Related]
25. Phosphodiesterase 5 inhibitor acts as a potent agent sensitizing acute myeloid leukemia cells to 67-kDa laminin receptor-dependent apoptosis.
Kumazoe M; Kim Y; Bae J; Takai M; Murata M; Suemasu Y; Sugihara K; Yamashita S; Tsukamoto S; Huang Y; Nakahara K; Yamada K; Tachibana H
FEBS Lett; 2013 Sep; 587(18):3052-7. PubMed ID: 23916810
[TBL] [Abstract][Full Text] [Related]
26. [Antisense oligodeoxynucleotide of telomerase gene enhances cisplatin-induced apoptosis in acute myeloid leukemia and chronic myeloid leukemia cells].
He D; Zhang H
Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):654-6. PubMed ID: 11769715
[TBL] [Abstract][Full Text] [Related]
27. Crucial role of heme oxygenase-1 in the sensitivity of acute myeloid leukemia cell line Kasumi-1 to ursolic acid.
Ma D; Fang Q; Li Y; Wang J; Sun J; Zhang Y; Hu X; Wang P; Zhou S
Anticancer Drugs; 2014 Apr; 25(4):406-14. PubMed ID: 24413389
[TBL] [Abstract][Full Text] [Related]
28. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W
Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247
[TBL] [Abstract][Full Text] [Related]
29. X-linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery.
Zhou J; Lu X; Tan TZ; Chng WJ
Mol Oncol; 2018 Jan; 12(1):33-47. PubMed ID: 29063676
[TBL] [Abstract][Full Text] [Related]
30. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
31. p53 and redox state in etoposide-induced acute myeloblastic leukemia cell death.
Koistinen P; Siitonen T; Mäntymaa P; Savolainen ER
Leuk Res; 2001 Dec; 25(12):1099-105. PubMed ID: 11684284
[TBL] [Abstract][Full Text] [Related]
32. The poly(ADP-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by NF-κB activation.
Faraoni I; Aloisio F; De Gabrieli A; Consalvo MI; Lavorgna S; Voso MT; Lo-Coco F; Graziani G
Cancer Lett; 2018 Jun; 423():127-138. PubMed ID: 29526802
[TBL] [Abstract][Full Text] [Related]
33. Quercetin simultaneously induces G
Chang JL; Chow JM; Chang JH; Wen YC; Lin YW; Yang SF; Lee WJ; Chien MH
Environ Toxicol; 2017 Jul; 32(7):1857-1868. PubMed ID: 28251795
[TBL] [Abstract][Full Text] [Related]
34. BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib.
Faraoni I; Compagnone M; Lavorgna S; Angelini DF; Cencioni MT; Piras E; Panetta P; Ottone T; Dolci S; Venditti A; Graziani G; Lo-Coco F
Biochim Biophys Acta; 2015 Mar; 1852(3):462-72. PubMed ID: 25483710
[TBL] [Abstract][Full Text] [Related]
35. The simultaneous inhibition of the mTOR and MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia.
Espinoza JL; Elbadry MI; Taniwaki M; Harada K; Trung LQ; Nakagawa N; Takami A; Ishiyama K; Yamauchi T; Takenaka K; Nakao S
Cancer Lett; 2017 Aug; 400():127-136. PubMed ID: 28456658
[TBL] [Abstract][Full Text] [Related]
36. PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect.
Cristóbal I; Garcia-Orti L; Cirauqui C; Alonso MM; Calasanz MJ; Odero MD
Leukemia; 2011 Apr; 25(4):606-14. PubMed ID: 21233840
[TBL] [Abstract][Full Text] [Related]
37. Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked inhibitor of apoptosis protein and B-cell lymphoma-extra large.
Friesen C; Roscher M; Hormann I; Leib O; Marx S; Moreno J; Miltner E
Eur J Cancer; 2013 Jul; 49(11):2542-54. PubMed ID: 23684782
[TBL] [Abstract][Full Text] [Related]
38. Differential responses of Bcl-2 family genes to etoposide in chronic myeloid leukemia K562 cells.
Fukumi S; Horiguchi-Yamada J; Nakada S; Nagai M; Ohno T; Yamada H
Mol Cell Biochem; 2000 Mar; 206(1-2):43-50. PubMed ID: 10839193
[TBL] [Abstract][Full Text] [Related]
39. Costunolide-induced apoptosis is caused by receptor-mediated pathway and inhibition of telomerase activity in NALM-6 cells.
Kanno S; Kitajima Y; Kakuta M; Osanai Y; Kurauchi K; Ujibe M; Ishikawa M
Biol Pharm Bull; 2008 May; 31(5):1024-8. PubMed ID: 18451540
[TBL] [Abstract][Full Text] [Related]
40. Meisoindigo is a promising agent with in vitro and in vivo activity against human acute myeloid leukemia.
Lee CC; Lin CP; Lee YL; Wang GC; Cheng YC; Liu HE
Leuk Lymphoma; 2010 May; 51(5):897-905. PubMed ID: 20233051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
